August 14, 2026 H.C. Wainwright & Co. – Advancing Dual-Asset Pipeline with Two Key Readouts on the Horizon; 2Q26 Results August 14, 2026 Maxim Group – 2Q26 Review & Outlook: Multiple Near-Term Events with Readouts in ALS and Metabolic Disease May 27, 2026 H.C. Wainwright & Co. – Tipelukast Enters Final Stretch Before Key Phase March 23, 2026 Maxim Group – Resumption of Coverage Report March 16, 2026 H.C. Wainwright & Co. – Initiation Report January 30, 2026 D. Boral Capital – Company Update Reportt January 5, 2026 Lucid Capital Markets – Initiation Report December 8, 2025 D. Boral Capital – Company Update Report December 4, 2024 D. Boral Capital – Initiation Report
August 14, 2026 H.C. Wainwright & Co. – Advancing Dual-Asset Pipeline with Two Key Readouts on the Horizon; 2Q26 Results
H.C. Wainwright & Co. – Advancing Dual-Asset Pipeline with Two Key Readouts on the Horizon; 2Q26 Results
August 14, 2026 Maxim Group – 2Q26 Review & Outlook: Multiple Near-Term Events with Readouts in ALS and Metabolic Disease
Maxim Group – 2Q26 Review & Outlook: Multiple Near-Term Events with Readouts in ALS and Metabolic Disease
